Type 2 Diabetes Flashcards

(38 cards)

1
Q

What is the HbA1c for pre diabetes

A

42-47mmol/mol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the two diagnostic results for confirmed diabetes

A

HbA1c of 48 or more
fasting plasma BG of 7 or more

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is 2nd line when there is low CVD risk?

and if these dont work?

A

pioglitazone
sulphonylurea

SGLT2-i
DPP-4i

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is 2nd line when there is high CVD risk

A

SGLT2-i

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the treatment plan for high cvd risk and the patient does not tolerate metformin

A

SGLT2-i alone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is HbA1c target if pt is not taking any drugs associated with hypoglycaemia and being managed on lifestyle with/without single drug

A

48mmol/mol
6.5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is HbA1c target if pt is taking a drug associated with hypoglycaemia and being managed on lifestyle with/without single drug

A

53mmol/mol
7%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the HbA1c target for a patient on a single drug

A

53mmol/mol
7%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is classed as uncontrolled HbA1c for a patient on a single drug

A

more than 58mmol/mol
7.5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Metformin is what type of drug

what is its action

A

biguanide

Decreases gluconeogenesis and increases peripheral utilisation of glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MHRA for metformin

A

reduced vitamin B12 levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the side effects of metformin

A

lactic acidosis
GI - N&V, diarrhoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what increases the risk of lactic acidosis

A

reduced kidney function
increased alcohol intake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are examples of DPP-4i

A

alogliptin
linagliptin
sitagliptin
saxagliptin
vildagliptin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the action of DPP-4i

A

inhibits DPP-4 to increase insulin secretion and reduce glucagon secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is avoided and cautioned in DPP-4i

A

avoid in ketoacidosis
caution in heart failure

17
Q

What is a key side effect of DPP-4i

A

pancreatitis - stop if symptoms occur

18
Q

What is the action of pioglitazone

A

reduces peripheral insulin resistance

19
Q

What is a contraindication for pioglitazone

A

C/I in history of heart failure

20
Q

What are the 4 risks with taking pioglitazone

A

increased risk of bladder cancer
increased risk of bone fractures
increased risk of infection
increased risk of liver toxicity

21
Q

What are examples of sulphonylureas

A

Long acting: glibencamide, glimepiride

Short acting: gliclazide, tolbutamide

22
Q

What is a key side effect of sulphonylureas

A

HYPOglycaemia

23
Q

What is avoided for sulphonylureas

A

avoid prescribing in acute porphyria

avoid in hepatic and renal failure

long acting avoided in elderly

24
Q

What are examples of SGLT2-i

A

canagliflozin
dapagliflozin
empagliflozin
ertugliflozin

25
What is the action of SGLT2-i
inhibits SGLT2 in the renal proximal convolute tubule
26
what are the MHRA warnings for SGLT2-i
life threatening and fatal cases of DKA Monitor ketones if treatment interrupted for surgical procedures or illness fourniers gangrene - necrotising fascitis of genitalia or perineum canagliflozin ONLY - risk of lower limb amputation mainly toes
27
what needs to be correct prior to SLGT2-i initiation
SGLT2-i can cause volume depletion correct hypovolaemia before starting
28
What is there an increased risk of when taking SGLT2-is
increased risk of urinary tract infections
29
what needs to be monitored in SGLT2-i
renal function as can cause renal impairment
30
what are examples of GLP-1 agonist
dulaglutide exenatide liraglutide lixisenatide semaglutide tirzepatide
31
What is the action of GLP-1 agonists
increase insulin secretion, suppresses glucagon secretion and slows gastric emptying
32
what are the 3 MHRA warnings for GLP-1 agonists
DKA risk when concomitant insulin was rapidly reduced reminder of side effects and potential misuse - weight loss risk of pulmonary aspiration during general anaesthesia or deep sedation
33
What are the potential side effects of GLP-1 agonists
acute pancreatitis GI effects - weight loss, delayed gastric emptying, N&V dehydration - avoid fluid depletion
34
what are 2 other unconventional antidiabetics
acarbose meglitides - repaglinide and nateglinide
35
What is the action of acarbose
delay digestion and absorption of starch and sucrose
36
what is the action of meglitide
stimulates insulin secretion
37
Which antidiabetic medications make you gain, neutral and lose weight
gain - pioglitazone, sulphonylureas neutral - DPP-4i, metformin loss - SGLT2-i, GLP-1 agonists
38
Which antidiabetic medication is withdrawn if hypoxia is likely
metformin